Showing results (11-20 of 315) with videos related to
Sort By:
Pageof 32
Oncology (Williston Park, N.Y.)|February 23, 2007
Targeted focal therapy: a minimally invasive ablation technique for early prostate cancerE David Crawford, Al BarqawiUrology Case Reports|June 24, 2016
The Role of FSH in Prostate Cancer: A Case ReportSalvatore Catarinicchia, E David CrawfordReviews in Urology|October 6, 2006
Treatment of localized prostate cancerBulent Akduman, E David CrawfordCurrent Urology Reports|April 27, 2007
Bone metabolism and new targets for interventionBulent Akduman, E David CrawfordThe Journal of Urology|May 29, 2003
The management of high risk prostate cancerBulent Akduman, E David CrawfordOncology (Williston Park, N.Y.)|September 12, 2003
Recent advances in hormonal therapy for advanced prostate cancerSiam Oottamasathien, E David CrawfordTherapeutics and Clinical Risk Management|August 30, 2008
Leuprorelin depot injection: patient considerations in the management of prostatic cancerZinelabidine Abouelfadel, E David CrawfordClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancerRobert Dreicer, Daniel Petrylak, David Agus, et al.Therapeutic Advances in Urology|July 27, 2011
Targeted focal therapy for prostate cancer: a review of the literatureKathryn F Sullivan, E David CrawfordCancer Management and Research|August 18, 2011
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfortE David Crawford, Jason M PhillipsPageof 32